Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01942876 · ClinicalTrials.gov registry record · Phase 2
Preventing Drug Use in Low Income Clinic Populations
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 411
- Enrollment target
NCT01942876: Completed Phase 2 study, sponsored by University of California, Los Angeles.
NCT01942876 is a Phase 2 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 411 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (209% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01942876, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 411 participants
- Enrollment target
Study Summary
The proposed study will address the critical need to reduce illegal drug use, in particular drug use, and the occurrence of drug-related harm in low-income racially diverse patient populations at urban primary care safety-net clinics. Since they are at risk for accelerated trajectories to drug dependence once drug use begins, low-income racially diverse populations pose particular concern for public health policy makers and drug-use prevention efforts. The study will be the first to standardize drug screening and primary-care clinician delivered brief intervention among racially diverse "at risk" drug users, that is users with casual or frequent use without the physiological or psychological manifestations of dependence, to reduce their 'at risk' use of drugs, and it may effectively interrupt their pathway to dependence.
Interventions
- BEHAVIORAL Quit Using Drugs Intervention Trial
- BEHAVIORAL Health behavior maintenance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 411 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-02 |
| Phase | Phase 2 |
What the finished NCT01942876 record still lists
NCT01942876 is an interventional study that assigns participants to a tested intervention. The registered 411 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (209% higher).
The record links to 0 conditions, and to 2 interventions - of which Quit Using Drugs Intervention Trial is the first listed.
NCT01942876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01942876 about?
NCT01942876 is a clinical study titled "Preventing Drug Use in Low Income Clinic Populations". The proposed study will address the critical need to reduce illegal drug use, in particular drug use, and the occurrence of drug-related harm in low-income racially diverse patient populations at urban primary care safety-net clinics. Since they are at risk for accelerated trajectories to drug depen...
What is the current status of trial NCT01942876?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 411 participants. The study started on 2011-01. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01942876?
The interventions under investigation include: Quit Using Drugs Intervention Trial (BEHAVIORAL), Health behavior maintenance (BEHAVIORAL).
Who is sponsoring clinical trial NCT01942876?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01942876's enrollment target sits among peer trials
411 93rd of 2000 higher than 1,908 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia